Sharekhan recommended Hold rating on Sun Pharmaceutical Industries with a target price of Rs 510 in its research report dated May 27, 2020.
Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 525 in its research report dated May 27, 2020.
Prabhudas Lilladher recommended Hold rating on Sun Pharmaceutical Industries with a target price of Rs 467 in its research report dated May 28, 2020.
Dolat Capital is bullish on Sun Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 530 in its research report dated May 27, 2020.
ICICI Securities is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 528 in its research report dated May 27, 2020.
Prabhudas Lilladher recommended hold rating on Sun Pharmaceutical Industries with a target price of Rs 436 in its research report dated May 21, 2020.
Sharekhan recommended Hold rating on Sun Pharmaceutical Industries with a target price of Rs 460 in its research report dated November 13, 2019.
ICICI Direct recommended hold rating on Sun Pharmaceutical Industries with a target price of Rs 470 in its research report dated August 14, 2019.
HDFC Securities is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 545 in its research report dated August 14, 2019.
Sharekhan recommended Hold rating on Sun Pharmaceutical Industries with a target price of Rs 500 in its research report dated August 13, 2019.
ICICI Direct recommended hold rating on Sun Pharmaceutical Industries with a target price of Rs 460 in its research report dated May 29, 2019.
Sharekhan recommended Hold rating on Sun Pharmaceutical Industries with a target price of Rs 460 in its research report dated May 28, 2019.
HDFC Securities is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 600 in its research report dated May 29, 2019.
ICICI Direct recommended hold rating on Sun Pharmaceuticals with a target price of Rs 460 in its research report dated February 13, 2019.
Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 540 in its research report dated February 12, 2019.
Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 560 in its research report dated January 22, 2019.
ICICI Direct recommended hold rating on Sun Pharmaceuticals with a target price of Rs 460 in its research report dated December 04, 2018.
Sharekhan recommended Hold rating on Sun Pharma with a target price of Rs 525 in its research report dated December 04, 2018.
Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 760 in its research report dated November 13, 2018.
HDFC Securities is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 670 in its research report dated November 14, 2018.
Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 790 in its research report dated September 19, 2018.
Centrum recommended hold rating on Sun Pharma with a target price of Rs 580 in its research report dated September 17, 2018.
Motilal Oswal is bullish on Sun Pharma has recommended Buy rating on the stock with a target price of Rs 790 in its research report dated September 07, 2018.
HDFC Securities is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 670 in its research report dated August 16, 2018.